Renal Cancer

July 4, 2018

Adjuvant Interferon not Effective for Patients with Renal Cell Carcinoma

Charles H. Weaver, MD
July 4, 2018

Predicting Better Survival for Kidney Cancer Patients After Transplant

Charles H. Weaver, MD
July 4, 2018

Sorafenib Improves Outcome of Metastatic Renal Cell Carcinoma

Charles H. Weaver, MD
July 4, 2018

Axitinib Provides Activity in Kidney Cancer

Charles H. Weaver, MD
July 4, 2018

Biological Therapy May Afford Better Survival Time than Chemotherapy

Charles H. Weaver, MD
July 4, 2018

Nexavar® plus Interferon Effective in Metastatic Kidney Cancer

Charles H. Weaver, MD
July 3, 2018

More Frequent Use of Partial Nephrectomy May Benefit Kidney Cancer Patients

Charles H. Weaver, MD
July 3, 2018

Nephron-Sparing Surgery Effective in Early-Stage Renal Cancer

Charles H. Weaver, MD
July 3, 2018

IPM Produces Responses in Renal Cancer that Stops Responding to Immunotherapy

Charles H. Weaver, MD
July 3, 2018

Immune Therapy Promising for Advanced Renal Cell Cancer

Charles H. Weaver, MD
July 3, 2018

Thalidomide Produces Responses in Advanced Renal Cell Cancer

Charles H. Weaver, MD
July 2, 2018

The Biologic Therapy Is more Effective for Treatment of Renal Cancer

Charles H. Weaver, MD